TY - JOUR AU - Cui, Z. AU - Sheng, Z. AU - Yan, X. AU - Cao, Z. AU - Tang, K. PY - 2016 DA - 2016// TI - In Silico Insight into Potential Anti-Alzheimer’s Disease Mechanisms of Icariin JO - Int J Mol Sci VL - 17 UR - https://doi.org/10.3390/ijms17010113 DO - 10.3390/ijms17010113 ID - Cui2016 ER - TY - JOUR AU - Mantoani, S. P. AU - Chierrito, T. P. AU - Vilela, A. F. AU - Cardoso, C. L. AU - Martínez, A. AU - Carvalho, I. PY - 2016 DA - 2016// TI - Novel triazole-quinoline derivatives as selective dual binding site acetylcholinesterase inhibitors JO - Molecules VL - 21 UR - https://doi.org/10.3390/molecules21020193 DO - 10.3390/molecules21020193 ID - Mantoani2016 ER - TY - JOUR AU - Alzheimer’s, A. PY - 2015 DA - 2015// TI - Alzheimer’s disease facts and figures JO - Alzheimers Dement VL - 11 UR - https://doi.org/10.1016/j.jalz.2015.02.003 DO - 10.1016/j.jalz.2015.02.003 ID - Alzheimer’s2015 ER - TY - JOUR AU - Shaik, A. S. AU - Raja, A. E. AU - Vijayalakshmi, M. AU - Devalarao, G. PY - 2010 DA - 2010// TI - Alzheimer’s disease: pathophysiology and treatment JO - Int J Pharm Biosci VL - 1 ID - Shaik2010 ER - TY - JOUR AU - Kim, T. W. PY - 2015 DA - 2015// TI - Drug repositioning approaches for the discovery of new therapeutics for Alzheimer’s disease JO - Neurotherapeutics VL - 12 UR - https://doi.org/10.1007/s13311-014-0325-7 DO - 10.1007/s13311-014-0325-7 ID - Kim2015 ER - TY - JOUR AU - Rochais, C. AU - Lecoutey, C. AU - Gaven, F. AU - Giannoni, P. AU - Hamidouche, K. AU - Hedou, D. AU - Dubost, E. AU - Genest, D. AU - Yahiaoui, S. AU - Freret, T. AU - Bouet, V. PY - 2015 DA - 2015// TI - Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer’s disease: the design of donecopride JO - J Med Chem VL - 58 UR - https://doi.org/10.1021/acs.jmedchem.5b00115 DO - 10.1021/acs.jmedchem.5b00115 ID - Rochais2015 ER - TY - JOUR AU - Corbett, A. AU - Pickett, J. AU - Burns, A. AU - Corcoran, J. AU - Dunnett, S. B. AU - Edison, P. AU - Hagan, J. J. AU - Holmes, C. AU - Jones, E. AU - Katona, C. AU - Kearns, I. PY - 2012 DA - 2012// TI - Drug repositioning for Alzheimer’s disease JO - Nat Rev Drug Discov VL - 11 UR - https://doi.org/10.1038/nrd3869 DO - 10.1038/nrd3869 ID - Corbett2012 ER - TY - JOUR AU - Nikolic, K. AU - Mavridis, L. AU - Djikic, T. AU - Vucicevic, J. AU - Agbaba, D. AU - Yelekci, K. AU - Mitchell, J. B. PY - 2016 DA - 2016// TI - Drug design for CNS diseases: polypharmacological profiling of compounds using cheminformatic, 3D-QSAR and virtual screening methodologies JO - Front Neurosci VL - 10 UR - https://doi.org/10.3389/fnins.2016.00265 DO - 10.3389/fnins.2016.00265 ID - Nikolic2016 ER - TY - JOUR AU - Mucke, H. A. PY - 2015 DA - 2015// TI - The case of galantamine: repurposing and late blooming of a cholinergic drug JO - Future Sci OA VL - 1 UR - https://doi.org/10.4155/fso.15.73 DO - 10.4155/fso.15.73 ID - Mucke2015 ER - TY - JOUR AU - Oprea, T. I. AU - Mestres, J. PY - 2012 DA - 2012// TI - Drug repurposing: far beyond new targets for old drugs JO - AAPS J VL - 14 UR - https://doi.org/10.1208/s12248-012-9390-1 DO - 10.1208/s12248-012-9390-1 ID - Oprea2012 ER - TY - JOUR AU - Corbett, A. AU - Williams, G. AU - Ballard, C. PY - 2015 DA - 2015// TI - Drug repositioning in Alzheimer’s disease JO - Front Biosci (Schol Ed) VL - 7 UR - https://doi.org/10.2741/s432 DO - 10.2741/s432 ID - Corbett2015 ER - TY - JOUR AU - Nelson, P. T. AU - Alafuzoff, I. AU - Bigio, E. H. AU - Bouras, C. AU - Braak, H. AU - Cairns, N. J. AU - Castellani, R. J. AU - Crain, B. J. AU - Davies, P. AU - Tredici, K. AU - Duyckaerts, C. PY - 2012 DA - 2012// TI - Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature JO - J Neuropathol Exp Neurol VL - 71 UR - https://doi.org/10.1097/NEN.0b013e31825018f7 DO - 10.1097/NEN.0b013e31825018f7 ID - Nelson2012 ER - TY - JOUR AU - Jackson-Siegal, J. PY - 2005 DA - 2005// TI - Our current understanding of the pathophysiology of Alzheimer’s disease JO - Adv Stud Pharm VL - 2 ID - Jackson-Siegal2005 ER - TY - JOUR AU - Kumar, S. AU - Chowdhury, S. PY - 2014 DA - 2014// TI - Kinetics of acetylcholinesterase inhibition by an aqueous extract of Cuminum cyminum seeds JO - Int J Appl Sci Biotechnol VL - 2 UR - https://doi.org/10.3126/ijasbt.v2i1.9348 DO - 10.3126/ijasbt.v2i1.9348 ID - Kumar2014 ER - TY - JOUR AU - Kumar, S. AU - Chowdhury, S. PY - 2015 DA - 2015// TI - Kinetics of inhibition of butyrylcholinesterase by an aqueous extract of Cuminum cyminum JO - Pharm Biol Eval VL - 2 ID - Kumar2015 ER - TY - JOUR AU - Ul-Haq, Z. AU - Khan, W. AU - Kalsoom, S. AU - Ansari, F. L. PY - 2010 DA - 2010// TI - In silico modeling of the specific inhibitory potential of thiophene-2, 3-dihydro-1,5-benzothiazepine against BChE in the formation of β-amyloid plaques associated with Alzheimer’s disease JO - Theor Biol Med Model VL - 7 UR - https://doi.org/10.1186/1742-4682-7-22 DO - 10.1186/1742-4682-7-22 ID - Ul-Haq2010 ER - TY - JOUR AU - Dickerson, T. J. AU - Beuscher, A. E. AU - Rogers, C. J. AU - Hixon, M. S. AU - Yamamoto, N. AU - Xu, Y. AU - Olson, A. J. AU - Janda, K. D. PY - 2005 DA - 2005// TI - Discovery of acetylcholinesterase peripheral anionic site ligands through computational refinement of a directed library JO - Biochemistry VL - 44 UR - https://doi.org/10.1021/bi051613x DO - 10.1021/bi051613x ID - Dickerson2005 ER - TY - JOUR AU - Zhang, Y. W. AU - Thompson, R. AU - Zhang, H. AU - Xu, H. PY - 2011 DA - 2011// TI - APP processing in Alzheimer’s disease JO - Mol Brain VL - 4 UR - https://doi.org/10.1186/1756-6606-4-3 DO - 10.1186/1756-6606-4-3 ID - Zhang2011 ER - TY - JOUR AU - Hilpert, H. AU - Guba, W. AU - Woltering, T. J. AU - Wostl, W. AU - Pinard, E. AU - Mauser, H. AU - Mayweg, A. V. AU - Rogers-Evans, M. AU - Humm, R. AU - Krummenacher, D. AU - Muser, T. PY - 2013 DA - 2013// TI - β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease JO - J Med Chem VL - 56 UR - https://doi.org/10.1021/jm400225m DO - 10.1021/jm400225m ID - Hilpert2013 ER - TY - JOUR AU - Cole, S. L. AU - Vassar, R. PY - 2008 DA - 2008// TI - The role of amyloid precursor protein processing by BACE1, the β-secretase. Alzheimer disease pathophysiology JO - J Biol Chem VL - 283 UR - https://doi.org/10.1074/jbc.R800015200 DO - 10.1074/jbc.R800015200 ID - Cole2008 ER - TY - JOUR AU - Aprahamian, I. AU - Stella, F. AU - Forlenza, O. V. PY - 2013 DA - 2013// TI - New treatment strategies for Alzheimer’s disease: is there a hope? JO - Indian J Med Res VL - 138 ID - Aprahamian2013 ER - TY - JOUR AU - Chauhan, V. AU - Chauhan, A. PY - 2006 DA - 2006// TI - Oxidative stress in Alzheimer’s disease JO - Pathophysiology VL - 13 UR - https://doi.org/10.1016/j.pathophys.2006.05.004 DO - 10.1016/j.pathophys.2006.05.004 ID - Chauhan2006 ER - TY - JOUR AU - Huang, W. J. AU - Zhang, X. AU - Chen, W. W. PY - 2016 DA - 2016// TI - Role of oxidative stress in Alzheimer’s disease JO - Biomed Rep VL - 4 UR - https://doi.org/10.3892/br.2016.630 DO - 10.3892/br.2016.630 ID - Huang2016 ER - TY - JOUR AU - Son, S. Y. AU - Ma, J. AU - Kondou, Y. AU - Yoshimura, M. AU - Yamashita, E. AU - Tsukihara, T. PY - 2008 DA - 2008// TI - Structure of human monoamine oxidase A at 2.2-Å resolution: the control of opening the entry for substrates/inhibitors JO - Proc Natl Acad Sci USA VL - 105 UR - https://doi.org/10.1073/pnas.0710626105 DO - 10.1073/pnas.0710626105 ID - Son2008 ER - TY - JOUR AU - Binda, C. AU - Wang, J. AU - Pisani, L. AU - Caccia, C. AU - Carotti, A. AU - Salvati, P. AU - Edmondson, D. E. AU - Mattevi, A. PY - 2007 DA - 2007// TI - Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs JO - J Med Chem VL - 50 UR - https://doi.org/10.1021/jm070677y DO - 10.1021/jm070677y ID - Binda2007 ER - TY - JOUR AU - Veitinger, M. AU - Varga, B. AU - Guterres, S. B. AU - Zellner, M. PY - 2014 DA - 2014// TI - Platelets, a reliable source for peripheral Alzheimer’s disease biomarkers? JO - Acta Neuropathol Commun VL - 2 UR - https://doi.org/10.1186/2051-5960-2-65 DO - 10.1186/2051-5960-2-65 ID - Veitinger2014 ER - TY - JOUR AU - Finberg, J. P. AU - Rabey, J. M. PY - 2016 DA - 2016// TI - Inhibitors of MAO-A and MAO-B in psychiatry and neurology JO - Front Pharmacol VL - 7 UR - https://doi.org/10.3389/fphar.2016.00340 DO - 10.3389/fphar.2016.00340 ID - Finberg2016 ER - TY - JOUR AU - Esposito, Z. AU - Belli, L. AU - Toniolo, S. AU - Sancesario, G. AU - Bianconi, C. AU - Martorana, A. PY - 2013 DA - 2013// TI - Amyloid β, glutamate, excitotoxicity in Alzheimer’s disease: are we on the right track? JO - CNS Neurosci Ther VL - 19 UR - https://doi.org/10.1111/cns.12095 DO - 10.1111/cns.12095 ID - Esposito2013 ER - TY - JOUR AU - Danysz, W. AU - Parsons, C. G. PY - 2012 DA - 2012// TI - Alzheimer’s disease, β-amyloid, glutamate, NMDA receptors and memantine–searching for the connections JO - Br J Pharmacol VL - 167 UR - https://doi.org/10.1111/j.1476-5381.2012.02057.x DO - 10.1111/j.1476-5381.2012.02057.x ID - Danysz2012 ER - TY - JOUR AU - Butterfield, D. A. AU - Pocernich, C. B. PY - 2003 DA - 2003// TI - The glutamatergic system and Alzheimer’s disease JO - CNS Drugs VL - 17 UR - https://doi.org/10.2165/00023210-200317090-00004 DO - 10.2165/00023210-200317090-00004 ID - Butterfield2003 ER - TY - STD TI - Mitra A, Dey B. Therapeutic interventions in Alzheimer disease (Chap. 12). In: Kishore U, editor Neurodegenerative diseases. Intech; 2013. p. 291–317. doi:10.5772/54915. ID - ref31 ER - TY - JOUR AU - Parsons, C. G. AU - Danysz, W. AU - Dekundy, A. AU - Pulte, I. PY - 2013 DA - 2013// TI - Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer’s disease JO - Neurotox Res VL - 24 UR - https://doi.org/10.1007/s12640-013-9398-z DO - 10.1007/s12640-013-9398-z ID - Parsons2013 ER - TY - JOUR AU - Cerejeira, J. AU - Lagarto, L. AU - Mukaetova-Ladinska, E. PY - 2012 DA - 2012// TI - Behavioral and psychological symptoms of dementia JO - Front Neurol VL - 3 UR - https://doi.org/10.3389/fneur.2012.00073 DO - 10.3389/fneur.2012.00073 ID - Cerejeira2012 ER - TY - JOUR AU - Parida, P. R. AU - Yadav, R. N. AU - Shankar, B. R. AU - Chakraborty, D. I. AU - Das, A. AU - Singh, N. K. PY - 2012 DA - 2012// TI - In-silico protein ligand interaction study of typical antipsychotic drugs against dopaminergic D2 receptor JO - Int J Pharm Pharmceusci VL - 5 ID - Parida2012 ER - TY - JOUR AU - Meltzer, H. Y. PY - 1999 DA - 1999// TI - The role of serotonin in antipsychotic drug action JO - Neuropsychopharmacology VL - 21 UR - https://doi.org/10.1016/S0893-133X(99)00046-9 DO - 10.1016/S0893-133X(99)00046-9 ID - Meltzer1999 ER - TY - JOUR AU - Filip, M. AU - Bader, M. PY - 2009 DA - 2009// TI - Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system JO - Pharmacol Rep VL - 61 UR - https://doi.org/10.1016/S1734-1140(09)70132-X DO - 10.1016/S1734-1140(09)70132-X ID - Filip2009 ER - TY - JOUR AU - Chowdhury, S. AU - Kumar, S. PY - 2016 DA - 2016// TI - In vitro anti-acetylcholinesterase activity of an aqueous extract of Unicaria tomentosa and in silico study of its active constituents JO - Bioinformation VL - 12 UR - https://doi.org/10.6026/97320630012112 DO - 10.6026/97320630012112 ID - Chowdhury2016 ER - TY - JOUR AU - Nicolet, Y. AU - Lockridge, O. AU - Masson, P. AU - Fontecilla-Camps, J. C. AU - Nachon, F. PY - 2003 DA - 2003// TI - Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M210241200 DO - 10.1074/jbc.M210241200 ID - Nicolet2003 ER - TY - JOUR AU - Bajda, M. AU - Jończyk, J. AU - Malawska, B. AU - Filipek, S. PY - 2014 DA - 2014// TI - Application of computational methods for the design of BACE-1 inhibitors: validation of in silico modelling JO - Int J Mol Sci VL - 15 UR - https://doi.org/10.3390/ijms15035128 DO - 10.3390/ijms15035128 ID - Bajda2014 ER - TY - JOUR AU - Krueger, B. A. AU - Weil, T. AU - Schneider, G. PY - 2009 DA - 2009// TI - Comparative virtual screening and novelty detection for NMDA-GlycineB antagonists JO - J Comput Aided Mol Des VL - 23 UR - https://doi.org/10.1007/s10822-009-9304-1 DO - 10.1007/s10822-009-9304-1 ID - Krueger2009 ER - TY - JOUR AU - Turkmenoglu, F. P. AU - Baysal, İ. AU - Ciftci-Yabanoglu, S. AU - Yelekci, K. AU - Temel, H. AU - Paşa, S. AU - Ezer, N. AU - Çalış, İ. AU - Ucar, G. PY - 2015 DA - 2015// TI - Flavonoids from Sideritis species: human monoamine oxidase (hMAO) inhibitory activities, molecular docking studies and crystal structure of xanthomicrol JO - Molecules VL - 20 UR - https://doi.org/10.3390/molecules20057454 DO - 10.3390/molecules20057454 ID - Turkmenoglu2015 ER - TY - JOUR AU - Sastry, G. M. AU - Adzhigirey, M. AU - Day, T. AU - Annabhimoju, R. AU - Sherman, W. PY - 2013 DA - 2013// TI - Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments JO - J Comput Aided Mol Des VL - 27 UR - https://doi.org/10.1007/s10822-013-9644-8 DO - 10.1007/s10822-013-9644-8 ID - Sastry2013 ER - TY - STD TI - Schrödinger Release 2015-4: LigPrep, version 3.6, Schrödinger, LLC, New York, 2015. ID - ref43 ER - TY - JOUR AU - Friesner, R. A. AU - Murphy, R. B. AU - Repasky, M. P. AU - Frye, L. L. AU - Greenwood, J. R. AU - Halgren, T. A. AU - Sanschagrin, P. C. AU - Mainz, D. T. PY - 2006 DA - 2006// TI - Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes JO - J Med Chem VL - 49 UR - https://doi.org/10.1021/jm051256o DO - 10.1021/jm051256o ID - Friesner2006 ER - TY - STD TI - Small-Molecule Drug Discovery Suite 2015-4: QikProp, version 4.6, Schrödinger, LLC, New York, 2015. ID - ref45 ER - TY - JOUR AU - Wang, R. AU - Lu, Y. AU - Wang, S. PY - 2003 DA - 2003// TI - Comparative evaluation of 11 scoring functions for molecular docking JO - J Med Chem VL - 46 UR - https://doi.org/10.1021/jm0203783 DO - 10.1021/jm0203783 ID - Wang2003 ER - TY - JOUR AU - Johnson, G. AU - Moore, S. W. PY - 2006 DA - 2006// TI - The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design JO - Curr Pharm Des VL - 12 UR - https://doi.org/10.2174/138161206775193127 DO - 10.2174/138161206775193127 ID - Johnson2006 ER - TY - JOUR AU - Çokuğraş, A. N. PY - 2003 DA - 2003// TI - Butyrylcholinesterase: structure and physiological importance JO - Turk J Biochem VL - 28 ID - Çokuğraş2003 ER - TY - JOUR AU - Edmondson, D. E. AU - Binda, C. AU - Wang, J. AU - Upadhyay, A. K. AU - Mattevi, A. PY - 2009 DA - 2009// TI - Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases JO - Biochemistry VL - 48 UR - https://doi.org/10.1021/bi900413g DO - 10.1021/bi900413g ID - Edmondson2009 ER - TY - JOUR AU - Sharma, M. AU - Gupta, V. B. PY - 2012 DA - 2012// TI - Dual allosteric effect in glycine/NMDA receptor antagonism: a molecular docking simulation approach JO - Int J Drug Des Discov VL - 3 ID - Sharma2012 ER - TY - JOUR AU - Oprea, T. I. AU - Bauman, J. E. AU - Bologa, C. G. AU - Buranda, T. AU - Chigaev, A. AU - Edwards, B. S. AU - Jarvik, J. W. AU - Gresham, H. D. AU - Haynes, M. K. AU - Hjelle, B. AU - Hromas, R. PY - 2012 DA - 2012// TI - Drug repurposing from an academic perspective JO - Drug Discov Today Ther Strateg VL - 8 ID - Oprea2012 ER - TY - JOUR AU - Lee, H. M. AU - Kim, Y. PY - 2016 DA - 2016// TI - Drug repurposing is a new opportunity for developing drugs against neuropsychiatric disorders JO - Schizophr Res Treat VL - 2016 ID - Lee2016 ER - TY - JOUR AU - Seeman, P. AU - Lee, T. PY - 1975 DA - 1975// TI - Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons JO - Science VL - 188 UR - https://doi.org/10.1126/science.1145194 DO - 10.1126/science.1145194 ID - Seeman1975 ER - TY - JOUR AU - Suzuki, A. AU - Kondo, T. AU - Mihara, K. AU - Yasui-Furukori, N. AU - Otani, K. AU - Furukori, H. AU - Kaneko, S. AU - Inoue, Y. PY - 2001 DA - 2001// TI - Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report JO - Eur Arch Psychiatry Clin Neurosci VL - 251 UR - https://doi.org/10.1007/s004060170053 DO - 10.1007/s004060170053 ID - Suzuki2001 ER - TY - JOUR AU - Meltzer, H. Y. AU - Matsubara, S. AU - Lee, J. C. PY - 1989 DA - 1989// TI - Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values JO - J Pharm Exp Ther VL - 251 ID - Meltzer1989 ER - TY - JOUR AU - Horacek, J. AU - Bubenikova-Valesova, V. AU - Kopecek, M. AU - Palenicek, T. AU - Dockery, C. AU - Mohr, P. AU - Höschl, C. PY - 2006 DA - 2006// TI - Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia JO - CNS Drugs VL - 20 UR - https://doi.org/10.2165/00023210-200620050-00004 DO - 10.2165/00023210-200620050-00004 ID - Horacek2006 ER - TY - JOUR AU - Moerlein, S. M. AU - Perlmutter, J. S. AU - Markham, J. AU - Welch, M. J. PY - 1997 DA - 1997// TI - In vivo kinetics of [18F](N-methyl) benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding JO - J Cereb Blood Flow Metab VL - 17 UR - https://doi.org/10.1097/00004647-199708000-00002 DO - 10.1097/00004647-199708000-00002 ID - Moerlein1997 ER - TY - JOUR AU - Fielding, S. AU - Lal, H. PY - 1978 DA - 1978// TI - Behavioral actions of neuroleptics JO - Handb Psychopharmacol VL - 10 UR - https://doi.org/10.1007/978-1-4613-4042-3_3 DO - 10.1007/978-1-4613-4042-3_3 ID - Fielding1978 ER -